Yahoo Web Search

Search results

1. • UBS Group AG Has $167.76 Million Stock Holdings in Novartis AG (NYSE:NVS)

     ETF DAILY NEWS· 3 days ago

     UBS Group AG trimmed its stake in shares of Novartis AG (NYSE:NVS – Free Report) by 9.9% during the fourth quarter, according to its most recent disclosure with the Securities ...

2. • Level Four Advisory Services LLC Cuts Stock Position in Novartis AG (NYSE:NVS)

     ETF DAILY NEWS· 4 days ago

     Level Four Advisory Services LLC trimmed its holdings in shares of Novartis AG (NYSE:NVS – Free Report) by 5.9% during the 4th quarter, according to the company in its most ...

3. • 

     This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a...

     CNBC· 17 hours ago

     Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall...

4. • A corner of the cancer therapy market is heating up—Here are the names investors need to know

     CNBC· 17 hours ago

     There's been a lot of attention lately on a corner of the oncology market called radiopharmaceuticals. The therapy seeks to destroy cancer cells by binding a radioactive particle to a targeted ...

5. • Drugmaker Novartis to expand nuclear medicine factory near airport, creating 55 jobs - Indianapolis...

     Indianapolis Business Journal· 4 days ago

     A Swiss-based drugmaker plans to double the size of its Indianapolis manufacturing plant, which produces nuclear medicine imaging and therapy products for cancer, in a move that would create ...

6. • 

     ASCO24: An early look at cancer drug study results

     BioPharma Dive via Yahoo Finance· 15 hours ago

     Note: So-called late-breaking abstracts, which often feature particularly consequential trial findings, aren’t available until the day the relevant...

7. • Latest 340B ruling delivers blow to providers

     Healthcare Dive· 2 days ago

     The ruling is a win for drug manufacturers, who were previously threatened with fines from the federal government for violating guidance regarding which pharmacies they would send discounted ...

8. • 

     ​​How To Measure The Success Of Your Emerging Leader Program

     Forbes· 2 days ago

     The funny thing about all of these points is that they point to the same way of thinking:...

9. • 

     Erasca restructures; Novartis moves to complete MorphoSys deal

     BioPharma Dive via Yahoo Finance· 7 days ago

     The cancer biotech is laying off one-fifth of its staff and scrapping three drugs. Elsewhere, ...

10. • 

      Updates in Parkinson's, ICH, Migraine, Muscular Dystrophy

      Medscape· 1 day ago

      Prof Christoph Diener discusses his picks for updates in neurology that were published in April...